|View printer-friendly version|
TRHC Chairman, CEO, and Founder
The two-day program was moderated by SAB member and CEO of
Topics included “Marketing in a Connected World,” “The Evolving Role of the Pharmacist,” and “The Role of Pharmacy in Value-Based Care.” The meeting also included work sessions to explore trends in technologies as they relate to TRHC’s businesses.
Focusing on understanding the consumer, Ms. O’Brien discussed the drastic change in the consumer journey and spoke of the “holistic sum of consumer experiences” with a brand over time. “It’s important to think of a consumer in totality,” she said. Ms. O’Brien also highlighted the importance of not just engaging consumers, but providing them with a memorable experience to share. “People like to hear about things from their family and friends.”
TRHC (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. TRHC provides solutions for a range of payers, providers and other healthcare organizations. For more information, visit TRHC.com.
This press release includes forward-looking statements that we believe to be reasonable as of today’s date. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the